...
首页> 外文期刊>Brain research >Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
【24h】

Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.

机译:D2受体介导的雄性大鼠下丘脑结核漏斗多巴胺能神经元激活的证据是通过抑制声活动传入强啡能神经元而发生的。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to determine if D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic (TIDA) neurons occurs via afferent neuronal inhibition of tonically active inhibitory dynorphinergic neurons in the male rat. To this end, the effects of either surgical deafferentation of the mediobasal hypothalamus or administration of a kappa opioid receptor agonist (U-50,488) or antagonist (nor-binaltorphimine (NOR-BNI)) on D2 receptor-mediated activation of TIDA neurons were assessed. For comparison, the activity of mesolimbic DA neurons was also determined in these studies. TIDA and mesolimbic DA neuronal activities were estimated by measuring dopamine synthesis (accumulation of 3,4-dihydroxyphenylalanine (DOPA) following decarboxylase inhibition) and metabolism (concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC)) in terminals of these neurons in the median eminence and nucleus accumbens, respectively. Intraperitoneal administration of the D2 receptor agonist quinelorane caused a dose-dependent increase in DOPAC in the median eminence and a decrease in DOPAC in the nucleus accumbens; surgical deafferentation of the mediobasal hypothalamus prevented the effect of quinelorane in the median eminence, but not the nucleus accumbens. Activation of kappa opioid receptors with U-50,488 had no effect per se, but blocked quinelorane-induced increases in median eminence DOPA. In contrast, U-50,488 had no effect on DOPA in the nucleus accumbens of either vehicle- or quinelorane-treated rats. Blockade of kappa opioid receptors with NOR-BNI increased median eminence DOPA, and prevented the stimulatory effects of quinelorane on dopamine synthesis. Administration of prolactin also increased median eminence DOPA, but did not alter the ability of quinelorane to stimulate dopamine synthesis. Neither NOR-BNI nor prolactin had any effect on DOPA in the nucleus accumbens of vehicle- or quinelorane-treated rats. These results suggest that D2 receptor-mediated activation of TIDA neurons occurs via an afferent neuronal mechanism involving, at least in part, inhibition of tonically active inhibitory dynorphinergic neurons in the male rat.
机译:本研究的目的是确定D2受体介导的下丘脑结核漏斗多巴胺能(TIDA)神经元的激活是否通过对雄性大鼠的声调活性抑制性强啡能神经元的传入神经元抑制而发生。为此,评估了手术治疗中下丘脑下丘脑脱失力或施用阿片类阿片受体激动剂(U-50,488)或拮抗剂(降冰片碱(NOR-BNI))对D2受体介导的TIDA神经元活化的影响。 。为了进行比较,在这些研究中还确定了中脑边缘DA神经元的活性。通过测量中位这些神经元末端的多巴胺合成(去羧化酶抑制后3,4-二羟基苯丙氨酸(DOPA)的积累)和代谢(3,4-二羟基苯乙酸的浓度(DOPAC))来估算TIDA和中脑边缘DA神经元的活性。隆起和伏隔核。腹膜内给予D2受体激动剂奎诺环烷导致中位突出度DOPAC剂量依赖性增加,伏隔核中DOPAC剂量依赖性降低;对下丘脑下丘脑进行外科除贫术可防止喹诺拉烷对正中隆起的作用,但对伏隔核没有作用。用U-50,488激活κ阿片受体本身没有作用,但是阻止了喹诺烷诱导的中位显着性DOPA升高。相比之下,U-50,488对接受媒介物或喹啉烷治疗的大鼠伏隔核中的DOPA没有影响。用NOR-BNI阻断kappa阿片受体可增加中位显着性DOPA,并阻止喹诺烷对多巴胺合成的刺激作用。催乳素的给药也增加了中位显着性DOPA,但并未改变喹诺拉酮刺激多巴胺合成的能力。 NOR-BNI或催乳素对经媒介物或喹啉烷治疗的大鼠伏隔核中的DOPA均无影响。这些结果表明,D2受体介导的TIDA神经元的活化是通过传入神经元机制发生的,该传入神经元机制至少部分地抑制雄性大鼠中的声调活性抑制性强啡肽能神经元。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号